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Effect of 2,3-dimercaptosuccinic acid on nephrosclerosis in the Dahi
rat. I. Role of reactive oxygen species. 2,3-Dimercaptosuccinic acid
(DMSA), a suithydryl-containing chelator, has previously been shown to
reduce mean blood pressure in lead-treated rats. In the present study we
have demonstrated that DMSA (0.5% for 5 days every 2 weeks) also
reduces mean blood pressure in the DahI salt-sensitive (SS) rat. Six-week-
old DahI SS and salt resistant (SR) rats were placed on a 0.3% NaCI diet
for two weeks, followed by an 8% NaCl diet for four weeks. Eight SS and
8 SR rats remained untreated while 8 SS and 8 SR rats were treated with
DMSA. DMSA treatment ameliorated the mean blood pressure rise in the
Dahl SS rats (141 5 vs. 120 4 mm Hg at 6 weeks, P < 0.001).
Nephrosclerosis was severe in untreated SS rats but absent in treated SS
rats as well as in both treated and untreated SR rats. Reactive oxygen
species formation, as assessed by kidney cortex content of malondialde-
hyde (MDA) and immunohistochemical demonstration of nitrotyrosine (a
byproduct of peroxynitrite) in interlobular arteries, was increased in Dahl
SS rats, but abolished by DMSA (MDA 9.65 0.33 nmol/g wet wt,
untreated SS, vs. 6.46 0.51, treated SS, P < 0.001). The anti-nephro-
sclerotic action of DMSA was clearly disproportionate to the reduction in
blood pressure. We conclude that the effect of DMSA was related instead
to the reactive oxygen species scavenging properties of the thiol groups.
The ultimate goal of antihypertensive treatment is to protect
the heart, brain, kidney and blood vessels against hypertensive
injury. The structural renal abnormalities associated with hyper-
tension, collectively known as nephrosclerosis, include arterial
intimal and, to a lesser degree medial, fibrosis, arteriolar hyalin-
ization, tubulointerstitial fibrosis, and variable ischemic changes
of glomeruli [1]. Although hypertension has been thought to be
the proximate cause of these changes [1—3], there have been a
number of discrepancies reported [4—71 that call into question
whether this is a direct cause and effect relationship. In this
context, recent interest has been directed to the role of reactive
oxygen species as participants in the hypertensive state as well as
in the functional derangement and remodeling of cardiovascular
structures (8—11]. It has been demonstrated that antihypertensive
drugs that act as scavengers of reactive oxygen species and have
favorable hemodynamic effects, such as captopril [11, 12, indap-
amide [13] and cicletanine [14, 15], offer a greater degree of
protection against the development of nephrosclerosis in the
genetic hypertensive rat than other antihypertensive drugs that
lack such scavenging properties [12, 15].
Our laboratory has previously demonstrated that the metal
chelating agent, meso-2,3-dimercaptosuccinic acid [DMSA] has a
blood pressure lowering [16J, as well as a renal protective effect
[171 in rats with lead-induced hypertension and/or lead-induced
nephropathy. We speculated that these beneficial effects of
DMSA were related to its properties as a scavenger of reactive
oxygen species, either directly or through chelation of silicon, with
resultant enhancement of superoxide dismutase activity [18],
rather than via its action as a chelator of lead.
The present study was designed to investigate the effect of
DMSA on the renal and vascular lesions of the Dahl salt-sensitive
rat, a model which has similarities to a subgroup of human
hypertensives in which sodium contributes to the development of
high blood pressure [19], and to determine whether these effects
were mediated by scavenging of reactive oxygen species.
Methods
Animals
Six-week-old male DahI salt-sensitive (SS) and salt-resistant
(SR) rats (purchased from Harlan Sprague-Dawley, Indianapolis,
IN, USA), weighing approximately 200 grams at the initiation of
the study, were used for all experiments. Sixteen SS and 16 SR rats
were employed. All animals were fed for two weeks on a low salt
(0.3% NaC1) diet, followed by four weeks on a high salt (8%
NaCl) diet (Dyetts Inc., Bethlehem, PA, USA). Half of the
animals in each group, selected randomly, received 0.5% DMSA
(Sigma Chemical Co., St. Louis, MO, USA) in their drinking
water every two weeks for a five day period, beginning with the
first day of the low salt diet. The animals were sacrificed beginning
at six weeks after initiation of the experimental protocol and
extending to eight weeks (mean of 7 weeks), with equal distribu-
tion of subgroups at the time of sacrifice.
Measurement of blood pressure
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Conscious rats were placed in a restrainer and allowed to rest
inside the cage for 15 minutes prior to blood pressure measure-
ments. Rat tails were placed inside a tail cuff and the cuff was
inflated and released a few times to allow the animal to be
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conditioned to the procedure. After stabilization, four consecutive
readings of mean arterial blood pressure (MBP) were taken by an
IITC monitor (Woodland Hills, CA, USA), attached to an
oscilloscope, and averaged for presentation. These values were
obtained at baseline and at two week intervals thereafter.
Tissue processing
Kidneys and tail artery segments were removed after sacrifice.
Cross sectional kidney slices approximately 1 mm in thickness
were immersion fixed in 10% buffered formalin (pH 7.4) for light
microscopy and in 2.5% buffered glutaraldehyde for electron
microscopy. The remainder of each kidney was stored frozen at
—80°C for subsequent biochemical measurements. A 0.5 cm
section of tail artery, measured 2 cm from the anus, was divided
into sections and similarly processed. Kidney tissue for light
microscopy was embedded in paraffin and 2 micron sections were
stained with periodic acid-Schiff and hematoxylin and eosin.
Artery segments were embedded so that each was sectioned
coronally and stained with hematoxylin and eosin. Transmission
electron microscopy was performed on epon-embedded speci-
mens stained with lead citrate and uranyl. Details for tissue
processing have been previously described [201.
Immunostaining procedure for detection of nitrolyrosine in
paraffin section
For demonstration of nitrotyrosine, 4 micron paraffin sections
were cut, mounted on Superfrost-plus slides (Fisher Scientific,
Pittsburgh, PA, USA), and baked at 50°C overnight. Slides were
deparaffinized in xylene and rehydrated through graded ethanol
series to water. Immunostaining was by a three-step indirect
immuno-alkaline phosphatase procedure involving: (1) blocking
with normal horse serum, 1/10 dilution for 10 minutes (Flow
Laboratories, McLean, VA, USA); (2) incubation with primary
antibody—rabbit anti-nitrotyrosine polyclorial IgG, 1/10 dilution
for 60 minutes (Upstate Biotechnology Incorporated, Lake
Placid, NY, USA); (3) alkaline phosphatase-conjugated affinity
purified swine anti-rabbit immunoglobulins, 1/50 dilution for 30
minutes (Dako Corporation, Carpenteria, CA, USA); (4) alkaline
phosphatase-conjugated, affinity purified rabbit anti-mouse im-
munoglobulins, 1/50 dilution for 30 minutes (Dako Corporation).
Slides were rinsed with phosphate buffered saline, pH 7.4, after all
three antibody incubations. Indicator system was developed with
Vector Red Substrate (Vector Laboratories Inc., Burlingame, CA,
USA). Slides were counterstained with Gill's hematoxylin, air
dried and coverslippecl with ACCU Mount (Baxter Healthcare
Corporation, McGaw Park, IL, USA). For control studies, tissue
sections were also incubated with antinitrotyrosine antibody in the
presence of nitrotyrosine or with non-immune rabbit serum. The
slides were further processed as above. The technique followed
that described by Haddad et al [21] and Beckman et al [22], with
the exception that alkaline phosphatase label was used in place of
peroxidasc for better visualization of kidney tissue.
All tissue samples were evaluated independently and blindly by
two investigators (OR and AHC) on coded slides. A minimum of
100 nephrons in each kidney specimen was examined. A semi-
quantitative score was utilized to evaluate the severity of changes
in the glomeruli, vasculature and tubulointcrstitium. Glomeruli
with any degree of sclerosis or collapse (including obsolescence)
and thrombonecrotic lesions were graded as follows (modified
from Raij et al [231): 0 = 0%; 1 + = ito 25%; 2+ = 26 to 50%;
3+ = 51 to 75%; 4+ = 75 to 100%. Scoring of tubulointerstitial
lesions was performed by a method which evaluates tubular
atrophy and dilatation, and interstitial fibrosis, as follows (modi-
fied from Rosen et al [24]): 0 = no lesions; 1+ = very mild focal
dilation; 2+ = larger number of dilated tubules with widening of
interstitium; 3+ = extensive dilation of tubules with cyst forma-
tion and widening of interstitium; 4+ = atrophy of tubules.
Arcuate, interlobular and tail artery alterations were graded as
follows: 0 = no lesions; 1+ = mild muscular hypertrophy; 2+ =
twice normal muscle thickness; 3+ = greater than twice normal
muscle thickness; 4+ = fibrin deposition and almost complete
obliteration of lumen. Arteriolar alterations were graded as
follows: 0 = no lesions; 1+ = muscular thickening; 2+ =
subendothelial plasma protein deposition (hyalinization); 3+ =
severe subendothelial plasma protein deposits and/or combina-
tion with muscular thickening; 4+ = thrombonecrotic lesions with
fibrin obliteration of lumen. An average injury score for each
structural change was obtained by summating the individual
animal scores and dividing by the number of animals per group
(theoretical maximum score = 4). A cumulative injury score was
also derived by summating all injury scores for animals within
each group and dividing by the number of animals per group
(theoretical maximum score = 28).
Motphometric evaluation
Planimetric examinations of cross-sectioned interlobular arter-
ies (intrarenal arteries with outer diameter between 35 and 220
microns), afferent arterioles, and tail arteries, as well as of
glomeruli, were performed by means of a Zeiss drawing tube in
combination with a semiautomatic interactive image analysis
system (Zeiss-Morphomat 30), using the Bio Scan® Optimas (Bio
Scan Inc., Edmonds, WA, USA) software program operating
under Microsoft® Windows 3.1, linked to Microsoft® Excel 4.0
(Microsoft Corporation, Redmond, WA, USA) [25]. After mea-
suring the outer diameter of the vessels and the inner diameter,
the wall to lumen (W/L) ratios were calculated (except in the
group of untreated Dahi SS rats where the marked variability as
well as severity of the arterial and arteriolar lesions precluded
meaningful measurements). The glomerular major axis length
(defined as a real value that can be extracted from area screen
objects and gives length of major axis in calibrated units) and area
breadth (defined as a real value that can be extracted from area
screen objects and gives the sum of the maximum distance of the
boundary from either side of the major axis in calibrated units)
were also measured. In each kidney section, 25 glomeruli and a
minimum of 6 interlobular arteries and 3 afferent arterioles were
evaluated. Care was taken to make sure that structures were
limited to those in which the cross-sectioned profile was optimal;
as a result, only a small portion of arteries and arterioles met this
requirement. Each tail artery segment was measured along three
separate axes. All results were expressed in microns.
Biochemical methods
The HPLC technique for measurement of the malondialde-
hyde-thioharbituric acid adduct (MDA-TBA) was essentially as
described by Draper et al [26]. Kidney cortex was separated from
medulla, minced, and duplicate 0.5 g samples were placed in pyrex
test tubes, after which 5.0 ml of 10% TCA and 0.25 ml of 500 ppm
hutylated hydroxytoluene in methanol were added. The sample
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Baseline
SS
(N=8)
SS/D
(N=8)
SR
(N=8)
SRID
(N=8)
85 5 89 4 87 4 91 4
2 weeks 5° 109 4° 102 5 96 6
4 weeks 126 3° 114 4ah 112 4° 101 5
6 weeks 141 5° 120 4°° 102 6 103 4
was heated to boiling for 30 minutes, cooled and centrifuged at
2500 rpm for 10 minutes. Then 0.25 ml of supernate was combined
with 0.25 ml of saturated aqueous thiobarbituric acid solution and
boiled for 30 minutes. The reaction mixture was extracted with 1
ml of n-butanol, and a 0.50 ml aliquot of the extract was mixed
with 0.25 ml of methanol and 0.25 ml of mobile phase (15%
acetonitrile and 0.6% tetrahydrofuran in 5 mM phosphate buffer,
pH 7.0). Finally, 20 l of the mixture was diluted to 1 ml with
mobile phase and a 20 l aliquot injected onto a reverse phase
C18m Bondapak column (4.6 >< 250 mm, 5 m particle size)
monitored by fluorescence detection (Ex 515 nm, Em 550 nm;
Rainin Instruments, Inc., Waltham, MA, USA) Solvent flow rate
was 1 ml per mi Tetraethoxypropane reagent was used as
standard.
A second slice of kidney cortex was dried at 70°C for 24 hours,
then 10 mg duplicate samples of dried tissue were subjected to
emission spectroscopy for silicon and lead by methods previously
described [27].
Statistical analysis
Results were expressed as means SEM. Two way analysis of
variance was used to compare values in DMSA-treated and
untreated Dahi SS and SR rats in order to test for differences due
to type of animal, treatment, and interaction. Additional statistical
comparisons were made by two-tailed unpaired t-tests. Differ-
ences between groups were considered significant at P < 0.05.
Kendall non-parametric correlation was calculated between the
W/L ratios of tail arteries and MBP.
Results
Antihypertensive effect
The blood pressure values for all groups of rats, at baseline,
two, four and six weeks are shown in Table 1. The Dahi SS rats
demonstrated a time-dependent progressive increase in their
blood pressure when placed on a high salt diet at two weeks, in
contrast to the Dahi SR rats which showed no increase in their
blood pressure. However, this increment in blood pressure in the
DahI SS rats was significantly attenuated by DMSA administra-
tion, both at four weeks (114 12 vs. 126 8 mm Hg, P < 0.05)
and at six weeks (120 12 vs. 140 14 mm Hg, P < 0.001). Body
weights averaged 412 grams at the termination of the experiment
and did not differ between treatment groups.
Pathological studies
A total of 26 kidneys and tail arteries were available to be
examined by histological techniques and histomorphometry (SS =
8, SS/D = 7, SR = 6, SR/D = 5). Groups were defined as: SS,
Dahl salt-sensitive rats, untreated; SS/D, Dahl SS rats treated with
DMSA; SR, Dahi salt-resistant rats, untreated; SR/D, Dahl SR
rats treated with DMSA. Histological examination by light mi-
croscopy revealed no abnormalities in the Dahl SR rats, with or
without the administration of DMSA. The Dahi SS rats, on the
other hand, revealed two strikingly distinct groups. The rats not
given DMSA (Fig. 1A) showed glomerular segmental sclerosis in
all cases, predominantly in deep cortical glomeruli, and glomer-
ular thrombonecrotic lesions in 4 out of 8 cases. Tubular atrophy
and dilatation were also prominent, occurring in 7 out of 8 cases
and in 6 out of 8 cases, respectively. Interstitial fibrosis was found
in 3 cases. In all animals the interlobular arteries and afferent
arterioles showed varying degrees of injury (from 1+ to 4+; Fig.
1C). Finally, the juxtaglomerular apparatus was hyperplastic in
half of the animals. In marked contrast, the Dahl SS rats given
DMSA (Fig. 1B) showed only minimal glomerular segmental
sclerosis in 1 out of 7 cases, no thrombonecrotic lesions and no
tubulointerstitial alterations. The vascular lesions were also ab-
sent (Fig. 1D), except for one animal with minimal changes in the
interlobular arteries [1+]. The juxtaglomerular apparatus were
normal in all cases. Table 2 summarizes the injury scores for
glomeruli, tubulointerstitium, interlobular arteries and afferent
arterioles in all four groups.
Ultrastructural comparisons of glomeruli in all groups indicated
that in the untreated SS animals, the foot processes of visceral
epithelial cells were partially effaced, affecting approximately 50%
of these structures. Subendothelial aspects of some capillary walls
were slightly widened, containing a small amount of flocculent
material. Normal glomerular morphology obtained in the other
groups (Fig. 2 A, B). Similarly, arterial endothelium was swollen
in the untreated SS animals, and myocyte size was increased but
with unaltered intracellular structure whereas no changes were
noted in the SS animals treated with DMSA (Fig. 2 C, D).
Immunostaining for nitrotyrosine was dramatically different for
untreated SS animals as compared with the three remaining
groups and reagent controls. There was positive staining of
endothelial cells and smooth muscle cells and macrophages within
small arteries and arterioles, virtually limited to those vessels with
considerable hypertrophy of the muscularis (Fig. 3 A—C). In some
of the arterioles it was not possible to identify endothelium
because of the pronounced degree of hypertrophy and distortion
of the walls. In contrast, positive staining for nitrotyrosine was not
observed in vascular structures of the other animal groups (Fig.
3D). Slides prepared for control studies demonstrated negative
staining for all structures.
Morphometric analysis
The wall to lumen (W/L) ratios of afferent arterioles, interlob-
ular arteries, and tail arteries, and glomerular major axis length
and area breadth are shown in Table 3. As previously stated, no
attempt was made to measure the WIL ratios of afferent arterioles
and interlobular arteries of the untreated Dahl SS rats because of
the severity and marked variability of the lesions (Fig. 1). The WIL
ratio of the afferent arteriole of the DMSA-trcated Dahl SS rat
was not different from the Dahi SR rat (treated or untreated). On
the other hand, the WIL ratio of the afferent arteriole of the
DMSA-treated Dahl SR rat was significantly lower than the W/L
ratio of the untreated DahI SR rat (1.06 0.21 vs. 1.64 0.12,
P = 0.03). The interlobular artery showed equivalent W/L ratios
Table 1. Effect of DMSA (D) on mean blood pressure of DahI salt-
sensitive (SS) and salt-resistant (SR) rats
Results are expressed in mm Hg SEM.
P < 0.001 in comparison to baseline
hP < 0.05 in comparison to SS
P < 0.001 in comparison to SS
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Fig. 1. Comparison of light microscopic features of treated and untreated Dahi salt-sensitive rats. A. Glomerulus with segmental sclerosis at the left of the
figure. The remainder of the glomerulus displays mesangial widening with patent capillaries. Untreated rat (periodic acid-Schiff, original magnification
X80). B. Glomerulus as well as artery and arterioles without abnormal features. Treated rat (periodic acid-Schiff, original magnification X80). C.
Interlobular artery with marked mural thickening because of muscular hypertrophy and fibrin accumulation. The lumen cannot be clearly identified. The
afferent arteriole also displays muscular hypertrophy. Untreated rat (hematoxylin and eosin, original magnification X80). D. Interlobular artery (cross
section) with mild muscular hypertrophy. Treated rat (periodic acid-Schiff, original magnification X80).
Table 2. Effect of DMSA (D) on glomerular, tubulointerstitial, arterial,
and arteriolar injury scores in Dahl salt-sensitive (SS) and salt-resistant
(SR) rat?
SS SS/D SR
0
SR/D
0Glomerulosclcrosis 0.9 0.1
Thrombonecrosis 0.5 0.1 0 0
Tubular atrophy 1.4 0 0 0
Tubular dilation 1.0 0 0 0
Interstitial fibrosis 0.9 0 0 0
Arterial injury 1.9 0.1 0 0
Arteriolar injury 2.1 0 0 0
Average score based on grading from 0 to 4
in all 3 groups that were measured. The measures of glomerular
length and breadth were equivalent in the four groups, revealing
no evidence of glomerular hypertrophy. Of distinct interest were
the measurements of the W/L ratios of the tail arteries. The Dahl
SS rats had higher ratios than Dab! SR (3.13 0.16 in treated
Dahl SS vs. 2.47 0.11 in treated Dahl SR, P = 0.01), with no
differences caused by DMSA treatment (Fig. 4 A, B).
Biochemical measurements
The MDA-TBA content of kidney cortex in each group is
displayed in Figure 5. Statistical analysis by two-way analysis of
variance revealed a significant interaction term at P < 0.001. In
the Dahi SS group there was a significant difference in the kidney
MDA-TBA content between the DMSA-treated and untreated
rats at P < 0.00 1, implying increased lipid peroxidation as a result
of accumulation of reactive oxygen species [26, 28] (9.65 0.33
nmol/g wet wt in untreated Dab! SS rats, vs. 6.64 0.37 in
DMSA-treated SS rats). On the other hand, Dah! SR rats showed
no differences between treated and untreated animals.
Silicon and lead content of kidney cortex in the untreated DahI
SS rats were 4.95 0.59 and 2.23 0.34 ppm dry weight,
respectively. Neither silicon nor lead was affected by DMSA
treatment and no significant changes were noted between SS and
SR groups.
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Fig. 2. Ultrastructural comparison of
morpholo. A. Glomerulus in the untreated
Dahi salt-sensitive rat. Endothelial cells are
prominently swollen. The epithelial foot
processes are largely effaced (x6525). B.
Glomerulus in the DahI salt-sensitive rat
treated with DMSA. Endothelial cells are
normal as are basement membrane and
epithelial foot processes (X6430). C. Artery in
the untreated Dahl salt-sensitive rat.
Endothelial cells are swollen. There is necrosis
of a single medial smooth muscle cell
(arrow)(X4250). D. Artery in the Dahl salt-
sensitive rat treated with DMSA. Endothelial
cells and myocytes are normal (x6150).
Correlations
The Kendall correlation coefficient relating tail artery W/L ratio
and MBP failed to reach a level of significance (r = 0.213, P =
0.064).
Figure 6 shows the relationship between the cumulative injury
score and the MBP in each group. It is evident from this Figure
that, although MBP of the Dahi SS rat was reduced by DMSA
treatment, it was not restored to normal, whereas renal injury was
almost completely prevented.
Discussion
in the present study we have demonstrated that administration
of DMSA not only lowered the blood pressure of salt-loaded Dahl
SS rats, but also prevented the nephrosclerotic lesions that are
seen in this genetic model of hypertension. Characteristically,
Dahl SS rats develop focal glomerular sclerosis at a relatively early
age [29—31j. After administration of a high salt diet and the
development of severe hypertension, the kidneys demonstrate
marked mesangial matrix expansion, tubular casts, tubulointersti-
tial damage, and extensive focal and segmental glomeruloscierosis
[12—14, 29—311. Renal and systemic arterial changes have also
been described in the salt-induced hypertensive phase, consisting
of medial necrosis or hyperplasia, hypercellularity of the intima
and destruction of the internal elastic membrane with thrombus
formation, narrowing of the lumen, inflammatory cell infiltration
and periarterial collagen accumulation [12—14, 29—33].
.
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Fig. 2. Continued.
The glomerular, vascular and interstitial changes seen in the
Dahi SS rat are similar to human forms of nephrosclerosis.
Nephrosclerosis can be defined as a form of chronic renal injuly
resulting from chronic ischemia/anoxia secondary to narrowed
extrarenal and intrarenal arteries and intrarenal arterioles. Arte-
rial abnormalities are primarily those of intimal fibrosis/elastosis,
while afferent arteriolar lesions are the combination of muscular
hypertrophy and "insudative" lesions (precipitate of plasma pro-
teins, usually C3, non-immune mediated) beneath endothelium.
The result of arterial insufficiency is chronic ischemic collapse and
sclerosis of glomeruli, and tubular atrophy with interstitial fibro-
sis, mainly in the cortex [34].
The pathogcnesis of segmental glomeruloscierosis and its role
in the progression of renal disease is complex, multifactorial, and
still poorly defined, but several risk factors have been implicated
in the development of this lesion. These include increased gb-
merular capillary hydraulic pressure [35], glomerular hypertrophy
[361, hyperlipidemia [31], growth factors and cytokines released by
resident or infiltrating cells [37, 38] and proteinuria [31]. Although
Dahi SS rats fed a standard chow diet have been shown to have
normal gbomerular capillary pressure up to 20 weeks of age [31],
increased gbomerular capillary pressure and decreased pre-gbo-
merular arteriolar resistance have been shown to develop after
salt loading [39]. Gbomerular hypertrophy was not a factor in the
present study as the glomerular size in the Dahi SS rats was
equivalent to the Dahl SR, and treatment with DMSA had no
effect.
It has been suggested, in general, that acute injury to the
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Fig. 3. Immunostaining for nitrolyrosine in the untreated Dahi salt-sensitive rat. A. Small interlobular artery with positively stained macrophages in
thickened wall. The reaction product is indicated by red granular stain (arrows) (alkaline phosphatase, original magnification X80). B. Small interlobular
artery with positively stained endothelial cell (arrow) (alkaline phosphatase, X80). C. Similar artery as in B; primary antibody was not used. All cells
are negative. (alkaline phosphatase, original magnification X80). D. DahI salt-sensitive rat treated with DMSA. There is no staining of any cell (alkaline
phosphatase, original magnification X80).
glomerulus leads to activation and/or release of growth factors, tion of extracellular matrix, a common finding in glomeruloscle-
which could result in increased synthesis of extracellular matrix by rosis [37, 38]. An important factor incriminated in the progression
the mesangial cells and to a self-perpetuating cycle of accumula- of renal disease [40], and nephrosclerosis and glomeruloscierosis
Fig. 4. Tail arteries. A. DahI salt-sensitive rat treated with DMSA. The wall is thickened and the lumen is narrowed as compared with DahI salt-resistant
rat. B. Tail arteries. (hematoxylin and eosin, original magnifications X40).
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Table 3. Effect of DMSA (D) on glomerular and vascular morphometry in Dahi salt-senstive (SS) and salt-resistant (SR) rats
SS SS/D SR SR/D
N (8) (7) (6) (5)
Afferent arteriole — 1.38 0.11 1.64" 0.12 1.06" 0.21
Interlobular artery (WIL ratio)
Tail artery (W/L ratio)
—
3.12 0.27
1.30 0.11
3.13 0.16
1.37 0.09
2.87 0.15
1.40 0.10
2.47 0.11
Glornerular major axis length microns 175.9 5.6 170.8 6.0 172.0 5.1 171.5 4.2
Glomerular breadth microns 142.4 8 138.8 6.4 143.8 3.3 144.7 4.1
"Difference between SR and SR/D significant at P = 0.03
b Difference between SS/D and SR/D significant at P = 0.01
o0 140
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in particular [12—14, 15], is the accumulation of reactive oxygen
species. It has been remarked repeatedly, both in human and
animal studies [4—7], and confirmed in the present study, that
blood pressure changes per se do not adequately account for the
renal abnormalities of nephrosclerosis, nor the response of the
renal abnormalities to various treatment modalities. As clearly
demonstrated in Figure 6, blood pressure reduction by DMSA
was modest whereas the improvement of the renal pathological
changes was dramatic.
In the Dahl SS rat, antihypertensive agents with reactive oxygen
species scavenging properties offer a greater degree of renal and
vascular protection than would be expected from their hemody-
namic effects alone [11—15, 41]. The diuretic indapamide, which
exhibits antioxidant effects in vitro, not only reduces blood pres-
sure, proteinuria and urinary excretion of n-acetyl--D-glu-
cosaminidase, and increases glomerular filtration rate, hut also
markedly improves the glomerular, vascular and tubular injuries
in the DahI SS rat [13]. In contrast, trichioromethiazide, which
reduces the blood pressure to the same extent as indapamide,
does not lower lipid peroxide formation (a measure of reactive
oxygen species in the kidney) or exert protective effects on the
renal glomeruli or arteries [13]. In a similar fashion, the novel
antihypertensive scavenger of reactive oxygen species, cicletanine,
reduces the blood pressure of DahI SS rats to the same extent as
the diuretic trichloromethiazide, while also attenuating the func-
tional and morphological injuries to the kidney [14, 15]. These
reports have called attention to the role of reactive oxygen species
generated in injured tissues, not only in hypertension, but also in
other renal conditions. In fact, the role of the angiotensin
converting enzyme inhibitor, captopril, in attenuating the degree
of renal damage in diabetic [42] or adriamycin nephropathy [12]
has been attributed to the presence of a sulfhydryl moiety in its
chemical structure. The thiol group appears to act as a scavenger
of superoxide anions [11]. In addition, the thiol group, upon
reacting with nitric oxide, forms S-nitrosothiols, which protect
nitric oxide from inactivation by superoxide anion and enhance its
stability and potency [43—45].
In experimental hypertension, increased mural oxygen con-
sumption [46] and extensive reactive oxygen species formation
occur during the early stages [47], followed by membrane lipid
peroxidation and the release of lysosomal and hydrolytic enzymes
[48], which may bring drastic modifications in the chemistry of the
extracellular matrix. Glycosaminoglycan and especially collagen
are known to be sensitive to damage by reactive oxygen species
[49]. Not only are the glomeruli and intrarenal vessels affected in
the salt-loaded Dahi SS rat, but the aorta demonstrates medial
hypertrophy, expansion of intima and increased actin and myosin
[41]. These changes are reversed by treatment with cicletanine. Of
interest in the present study was the demonstration that a
resistance vessel outside the kidney, namely the tail artery, showed
a thickening of the arterial wall in the Dahl SS rat as compared to
the SR, which was not affected by DMSA treatment. Thus the
beneficial reactive oxygen species scavenging effect of DMSA may
not be universal.
Our laboratory has reported that DMSA has a blood pressure
lowering effect [16] and ameliorates the renal lesions in rats with
lead-induced nephropathy [17]. Because DMSA acts as an anti-
oxidant in vitro [16], we postulated that these beneficial effects
were related to the scavenging of reactive oxygen species, either
directly or through the chelation of silicon or lead, both known to
inhibit the activity of superoxide dismutase [18, 501. The resultant
generation of the reactive oxygen species, superoxide, has been
reported to lead to hypertension through direct vasoconstriction
[51, 52], or through inactivation of nitric oxide (endothelial-
derived relaxing factor) [10]. This hypothesis has been partially
Fig. 5. Effect of DMSA on renal malondialdehyde content in Dahl salt-
sensitive and salt-resistant rats. Symbols are: SS-untreated Dahl SS rats;
SS/D-Dahl SS rats treated with DMSA; SR-untreated DahI SR rats;
SR/D-Dahl SR rats treated with DMSA.
CD
C-
Fig. 6. Cumulative injury score related to mean blood pressure in untreated
and DMSA -treated Dahi salt-sensitive and salt-resistant rats. Symbols: ()
injury scoring; (S) mean blood pressure.
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corroborated by the in vivo results obtained in the present study.
We found in renal cortex homogenates of Dahi SS rats increased
levels of MDA-TBA, an index of lipid peroxidation, and, conse-
quently, of oxidative stress [281, while DMSA treatment of Dahi
SS rats returned kidney cortex MDA-TBA levels to normal. As
kidney cortex levels of silicon and lead were not affected by
DMSA, an alteration in the inhibition of superoxide dismutase by
these ions is not plausible. The in vivo as well as the prior in vitro
results are most consistent with a scavenging effect of DMSA,
presumably due to the presence of thiol groups [ii].
Further substantiation of the mechanism of action of DMSA
and the role of reactive oxygen species in producing tissue injury
was afforded by the demonstration that there was increased
nitrotyrosine present within macrophages and in the endothelium
of arteries in the untreated DahI SS rat, prevented by DMSA
treatment. Beckman and colleagues [221 have demonstrated that
extensive nitration of tyrosine is found in endothelium, foamy
macrophages and inflammatory cells associated with atheroma in
human coronary arteries. The nitrotyrosine formation is the result
of the attack on tissue proteins of peroxynitrite, a product of the
reaction between nitric oxide and the reactive oxygen species,
superoxide anion [51 It is possible that by scavenging reactive
oxygen species, DMSA could contribute to increased prostacyclin
generation [51, which not only prevents platelet aggregation, but
also mitigates smooth muscle cell growth [55, 561. The urinary
excretion and renomedullary synthesis of the prostaglandin,
PGE2, has been reported to be reduced in Dahi SS rats [29, 41],
while drugs whieh scavenge reactive oxygen species, such as
indapamide [131 and cicletanine [14, 151, have been shown to
enhance PGI2 synthesis.
In summary, we have demonstrated that DMSA abrogated the
blood pressure increase in salt fed Dahl SS rats, and also
prevented the development of nephrosclerotic renal lesions,
clearly disproportionate to the degree of blood pressure lowering.
Although the mechanisms involved in this protective effect of
DMSA are yet to be completely elucidated, it appears likely that
the reactive oxygen species scavenging properties of DMSA play
a central role.
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